Technical Analysis for BTTX - Better Therapeutics, Inc.

Grade Last Price % Change Price Change
F 0.01 8.53% 0.00
BTTX closed up 8.53 percent on Thursday, March 28, 2024, on 13 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Earnings Movers Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 8.53%
Narrow Range Bar Range Contraction 8.53%
Wide Bands Range Expansion 8.53%
Down 3 Days in a Row Weakness 8.53%
Oversold Stochastic Weakness 8.53%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 17 hours ago
Down 1% about 18 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
Up 5% about 21 hours ago
Up 3% about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Better Therapeutics, Inc. Description

Better Therapeutics is a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The cognitive behavioral therapy delivered by Better Therapeutics’ PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics clinically validated mobile applications are intended to be prescribed by physicians and reimbursed like traditional medicines.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Disease Health Sciences Diabetes FDA Health Informatics Heart Disease Healthcare Costs Behavior Modification Digital Therapeutics

Is BTTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.61
52 Week Low 0.012
Average Volume 7,177,518
200-Day Moving Average 0.39
50-Day Moving Average 0.15
20-Day Moving Average 0.10
10-Day Moving Average 0.02
Average True Range 0.02
RSI (14) 27.01
ADX 34.98
+DI 14.22
-DI 36.22
Chandelier Exit (Long, 3 ATRs) 0.15
Chandelier Exit (Short, 3 ATRs) 0.08
Upper Bollinger Bands 0.27
Lower Bollinger Band -0.08
Percent B (%b) 0.26
BandWidth 354.56
MACD Line -0.05
MACD Signal Line -0.04
MACD Histogram -0.0073
Fundamentals Value
Market Cap 760.94 Thousand
Num Shares 54.4 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -0.01
Price-to-Sales 49559.41
Price-to-Book 2.29
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.02
Resistance 3 (R3) 0.02 0.02 0.02
Resistance 2 (R2) 0.02 0.02 0.02 0.02
Resistance 1 (R1) 0.02 0.02 0.02 0.02 0.02
Pivot Point 0.01 0.01 0.01 0.01 0.01
Support 1 (S1) 0.01 0.01 0.01 0.01 0.01
Support 2 (S2) 0.01 0.01 0.01 0.01
Support 3 (S3) 0.01 0.01 0.01
Support 4 (S4) 0.01